Clinical trial

Reproducibility of an Immobilization Device (BodyFIX) - Hodgkins/Lymphoma

NCT00232440 · University Health Network, Toronto, Other · Completed

Key facts

NCT number NCT00232440
Title Reproducibility of an Immobilization Device (BodyFIX) - Hodgkins/Lymphoma
Official title A Study to Examine the Reproducibility of an Immobilization Device (BodyFIX ) to Deliver High Precision Radiation Therapy for Patients With Hodgkin's Disease or Non-Hodgkin's Lymphoma
Lead sponsor University Health Network, Toronto, Other
Collaborators Princess Margaret Hospital, Canada
Status Completed
Phase Phase 1/Phase 2
Study type Interventional
Conditions Hodgkin's Disease, Lymphoma, Non-Hodgkin
Intervention type Device
Interventions BodyFIX
Enrollment 20
Start date Jan 1, 2003
Primary completion Jun 1, 2009
Completion Jun 1, 2009
First posted Oct 4, 2005
Last update posted Aug 11, 2010
Countries Canada

At a glance

  • 1–9 Study sites
  • No Results posted
  • None Linked FDA submissions

Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.

About ClinicalTrials.gov studies

ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.

Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date:

Browse all ClinicalTrials.gov studies